Nanalysis Completes $3.4 Million Private Placement with Closing of Second Tranche

Nanalysis Scientific ( (TSE:NSCI) ) has issued an announcement.

Nanalysis Scientific Corp. has completed the second and final tranche of its previously announced $3.4 million non-brokered private placement, issuing 6,145,300 units at $0.15 per unit for additional gross proceeds of $921,795, bringing the total units issued under the offering to 22,671,583. Each unit comprises one common share and one-half common share purchase warrant, with warrants exercisable at $0.20 for two years and subject to an acceleration clause, while the securities carry a four-month-plus-one-day hold period and the transaction remains subject to final TSX Venture Exchange acceptance, providing the company with fresh equity capital to support its ongoing operations and growth initiatives.

The most recent analyst rating on (TSE:NSCI) stock is a Buy with a C$0.50 price target. To see the full list of analyst forecasts on Nanalysis Scientific stock, see the TSE:NSCI Stock Forecast page.

More about Nanalysis Scientific

Nanalysis Scientific Corp. develops and manufactures portable nuclear magnetic resonance (NMR) spectrometers used globally across pharmaceutical, biotech, energy, food, materials and security industries, as well as in academic and government laboratories. The Calgary-based company also operates a growing services division that maintains both its own products and third-party imaging equipment, underpinned by a $160 million long-term contract with the Canadian Air Transport Security Authority to service security scanners at more than 80 Canadian airports.

YTD Price Performance: -2.94%

Average Trading Volume: 88,338

Technical Sentiment Signal: Sell

Current Market Cap: C$21.83M

See more insights into NSCI stock on TipRanks’ Stock Analysis page.